UGER ROBERT (Chief Scientific Officer) sold 8.52K shares of TRILLIUM THERAPEUTICS INC. on the open market
Open‑market sale worth $133.8K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/12/2021ACC: 0001062993-21-000291
Officer· Chief Scientific Officer
Since Jan 2021
-8.52K
Net shares
Net seller
$133.8K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
8.52K acquired · 17.03K disposed
Non-Derivative Transactions4
Common Shares
Direct
Shares
+5.60K
Price / share
$11.01
Trade value
$61.65K
% of position
New position
1/8/2021
0.00→5.60K
Common Shares
Direct
Shares
−5.60K
Price / share
$15.82
Trade value
$88.58K
% of position
New position
1/8/2021
5.60K→0.00
Common Shares
Direct
Shares
+2.92K
Price / share
$3.33
Trade value
$9.72K
% of position
New position
1/8/2021
0.00→2.92K
Common Shares
Direct
Shares
−2.92K
Price / share
$15.51
Trade value
$45.23K
% of position
New position
1/8/2021
2.92K→0.00
Total
Net shares
+0.00
Net value
-$62.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/8/2021 | M · Option Exercise | +5.60K | $11.01 | $61.65K | New position | 0.00 | 5.60K |
| Common Shares Direct | 1/8/2021 | S · Sale | −5.60K | $15.82 | $88.58K | New position | 5.60K | 0.00 |
| Common Shares Direct | 1/8/2021 | M · Option Exercise | +2.92K | $3.33 | $9.72K | New position | 0.00 | 2.92K |
| Common Shares Direct | 1/8/2021 | S · Sale | −2.92K | $15.51 | $45.23K | New position | 2.92K | 0.00 |
| Total | +0.00 | -$62.44K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
5.60K shares
Shares
−5.60K
Strike price
11.0087
Held after
23.47K
Exercisable
—
1/8/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
2.92K shares
Shares
−2.92K
Strike price
3.3310
Held after
64.17K
Exercisable
—
1/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares5.60K shares | 1/8/2021 | M · Option Exercise | −5.60K | 11.0087 | — | 23.47K |
| Stock Option (Right to Buy) Direct | Common Shares2.92K shares | 1/8/2021 | M · Option Exercise | −2.92K | 3.3310 | — | 64.17K |